Status:
COMPLETED
Conservation of Red Cell Mass , Oxygen Supply and Demand in Cardiac Surgery
Lead Sponsor:
Virginia Commonwealth University
Collaborating Sponsors:
Daxor Corporation
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-90 years
Brief Summary
Fifty patients will be enrolled into the study. The purpose of the study is to investigate the relevance of Hct levels in determining need for transfusion during operations employing bypass as well as...
Detailed Description
Fifty adults( male or female-nonpregnant) whose weight is between 55-85 kg and are scheduled to undergo elective cardiac surgery with cardiopulmonary bypass for CABG or primary valve repair or replace...
Eligibility Criteria
Inclusion
- Patient scheduled to undergo elective Cabg or primary repair/replacement on bypass pump.
- Age 18 yrs or older
- Male or non pregnant female
- Weight between 55-85 kg.
Exclusion
- Any known bleeding risks;
- Urgent or emergent surgery;
- Combined aortic and major vascular surgery;
- Pregnant women
- If participating in another study within last 90 days.
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2010
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00660608
Start Date
April 1 2008
End Date
April 1 2010
Last Update
July 5 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VCU Medical Center
Richmond, Virginia, United States, 23298